COO Milnes Alistair Buys 150,000 Shares in Strategic Move at Bicycle Therapeutics – Signals Long‑Term Optimism Amid Market Volatility
COO Milnes Alistair’s January 2026 RSU award and option purchase signal strategic confidence in Bicycle Therapeutics’ future, hinting at potential upside despite current market volatility.
3 minutes to read